CHRS vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

CHRS

61.2
AI Score
VS
CHRS Wins

CLYM

44.4
AI Score

Investment Advisor Scores

CHRS

61score
Recommendation
BUY

CLYM

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CHRS CLYM Winner
Net Income -209.34M -27.22M CLYM
Operating Income -204.42M -30.57M CLYM
ROE 542.5% -11.4% CHRS
ROA -210.5% -11.1% CLYM
Total Assets 99.47M 246.29M CLYM
Cash 72.36M 44.11M CHRS
Current Ratio 2.54 31.45 CLYM
Free Cash Flow -160.06M -25.18M CLYM

Relative Price Performance (Last 90 Days)

CHRS 1M: -18.3% · 3M: -25.6% CLYM 1M: -27.3% · 3M: -17.6%

Current Technical Phase

CHRS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 41

RSI (14): 41.0 · Price: $1.16

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.3 · Price: $10.94

Fundamentals Snapshot

Metric CHRS CLYM
Market Cap — —
Forward P/E -1.8 -10.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.4% 0.0%
Gross Margin 0.7% —
Operating Margin -2.3% 0.0%
EPS -1.19 -0.79
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CHRS is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.